Effects of Long-term Prophylactic Use of Rifaximin-a on Intestinal Microbial Composition and Resistome in Patients with Liver Cirrhosis

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
This article has no abstract
Epistemonikos ID: 41fc4ed8d681f5db5952cd97ed05508a9581fd83
First added on: Apr 07, 2025